Experimental Drug (teplizumab) May Fight Type 1 Diabetes
Previously Published on WebMD – MONDAY, March 8, 2021 (HealthDay News) — Just two weeks of treatment with an experimental drug can delay the onset of type 1 diabetes by several years, researchers report. The drug, called teplizumab, is already under review by the U.S. Food and Drug Administration based on earlier evidence of its effectiveness….